Multinational drug makers seem hell bent upon forcing the government to alter the patent regulations in their favour.

GlaxoSmithKline (GSK) announced that the Commercial Court in Dublin, Ireland, ruled in patent litigation regarding GSK's product Seretide, an inhaled respiratory treatment for asthma and COPD.

The National Pharmaceutical Pricing Authority (NPPA) has issued notices to 22 pharma companies across the country in the last three months seeking explanation for violating the price regulation by selling drugs in higher than the prices fixed by the authority.

Union government is formulating a policy for traceability in packaging for the pharmaceutical sector. The traceability norms are expected to put an end to the undesirable use of recycled bottles by the pharmaceutical companies.